InfuSystem Holdings, Inc. Announces Christopher Sansone Decides Not to Stand for Re-Election to the Board of Directors
March 28, 2023 at 05:08 pm EDT
Share
On March 24, 2023, Christopher Sansone notified InfuSystem Holdings, Inc. (the Company) of his decision not to stand for re-election to the Board of Directors of the Company (the "Board") when his current term expires on the date of the Company's 2023 Annual Meeting of Stockholders. Mr. Sansone's decision is based solely on personal reasons and not because of any disagreement or dispute with the Board or the Company on any matter, including with respect to the Company's operations, policies or practices.
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segmentâs core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.